Cancer Genetics Laboratory, Centre for Translational Cancer Research (Te Aho Matatū), Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Cancer Genetics Laboratory, Centre for Translational Cancer Research (Te Aho Matatū), Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Gastroenterology. 2023 Apr;164(5):719-735. doi: 10.1053/j.gastro.2023.01.038. Epub 2023 Feb 4.
Hereditary diffuse gastric cancer (HDGC) is a dominantly inherited cancer syndrome characterized by a high incidence of diffuse gastric cancer (DGC) and lobular breast cancer (LBC). HDGC is caused by germline mutations in 2 genes involved in the epithelial adherens junction complex, CDH1 and CTNNA1. We discuss the genetics of HDGC and the variability of its clinical phenotype, in particular the variable penetrance of advanced DGC and LBC, both within and between families. We review the pathology of the disease, the mechanism of tumor initiation, and its natural history. Finally, we describe current best practice for the clinical management of HDGC, including emerging genetic testing criteria for the identification of new families, methods for endoscopic surveillance, the complications associated with prophylactic surgery, postoperative quality of life, and the emerging field of HDGC chemoprevention.
遗传性弥漫性胃癌(HDGC)是一种显性遗传的癌症综合征,其特征是弥漫性胃癌(DGC)和小叶乳腺癌(LBC)的发病率较高。HDGC 是由上皮细胞黏着连接复合物中的 2 个基因的种系突变引起的,这 2 个基因分别是 CDH1 和 CTNNA1。我们讨论了 HDGC 的遗传学及其临床表型的可变性,特别是先进的 DGC 和 LBC 在家族内和家族间的可变外显率。我们回顾了疾病的病理学、肿瘤发生的机制及其自然病史。最后,我们描述了 HDGC 的临床管理的最佳实践,包括用于识别新家族的新兴遗传测试标准、内镜监测方法、预防性手术相关的并发症、术后生活质量以及新兴的 HDGC 化学预防领域。